Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study to Evaluate the Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic Non-squamous NSCLC or Extensive-stage SCLC or Advanced TNBC Under First-line Treatment With Atezolizumab in Combination With Chemotherapy

NCT03911219 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT03911219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study to Evaluate the Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic Non-squamous NSCLC or Extensive-stage SCLC or Advanced TNBC Under First-line Treatment With Atezolizumab in Combination With Chemotherapy
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
July 10, 2019
Completion date
July 1, 2021
Enrollment
154 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

advanced (locally advanced and inoperable or metastatic), pd-l1 ic-positive tnbc, extensive-stage small cell lung cancer, stage iv non-small cell lung cancer